DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Geron Corp (NASDAQ: GERN)

4.30 -0.03 (-0.69%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GERN $4.30 -0.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.33
Previous Close $4.33
Daily Range $4.30 - $4.45
52-Week Range $1.69 - $4.49
Market Cap $678.1M
P/E Ratio -18.83
Dividend (Yield) $0.00 (0.0%)
Volume 3,132,076
Average Daily Volume 3,166,893
Current FY EPS -$0.09

Sector

Healthcare

Industry

Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary

The Reason Behind Geron Corporation's 25% Catapult Higher in March

A favorable fourth-quarter earnings report and an even more favorable view from one Wall Street firm set the stage for a great March for Geron. But, can the good times keep rolling?

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pha

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases

Health Care Sector Update for 04/21/2015: GERN, MYL, TEVA, NVGN, JNJ

Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog

Oppenheimer Is Excited About These 3 Biotech Stocks

3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog

Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape

Weak On High Volume: Geron (GERN)

Some Questions For Dr. Scarlett, CEO Of Geron

Today's Dead Cat Bounce Stock: Geron (GERN)

See More GERN News...

GERN's Top Competitors

GERN $4.30 (-0.69%)
Current stock: GERN
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB